Skip to main content

Eligard (leuprorelin acetate) | For UK Healthcare Professionals

This promotional website has been developed and funded by Recordati Pharmaceuticals Ltd and is only intended for healthcare professionals based in the UK.
Prescribing Information (PI) and Adverse Event (AE) Reporting Information can be accessed via the link found at the bottom of this page.

CONTACT US

Asset 1

Contact us for more information










    I give my consent to receive promotional and non-promotional digital communications on drugs and products marketed by the Recordati Group (including sending invitations to participate in congresses, conferences or medical-scientific meetings, disease awareness information, planning visits and supplying samples, webinars and training events organized or sponsored by Recordati) through the following channels:

    I give my consent to Recordati to share my personal data with the other companies belonging to the Recordati Group for the performance of their independent medical, scientific, and promotional information purposes on the drugs and products marketed by them. The list of Recordati Group companies in each country is available on our website www.recordati.com.

    Recordati Pharmaceuticals Ltd. ("Recordati") is constantly committed in respecting the privacy of individuals with whom it comes into contact. If you wish to receive scientific information communications from Recordati on drugs and products marketed by the Recordati Group, to be contacted for promotional purposes, and/or to allow the sharing of your personal data with other companies belonging to the Recordati Group, these activities will be carried out only with your consent. For complete information regarding the processing of your personal data by Recordati, please read our Privacy Notice.